Suchergebnisse - "Benhamou, Yves"

PubPharm (218)

1

Including Ratio of Platelets to Liver Stiffness Improves Accuracy of Screening for Esophageal Varices That Require Treatment

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2021

von Berger, A. | Ravaioli, F. | Farcau, O. | +70

2

Erschienen: Les Ulis, EDP Sciences, [2021]

Monographie

von Pawlotsky, J. | Alter, H. | Antona, D. | +49

3

Identification of an Endoglin Variant Associated With HCV-Related Liver Fibrosis Progression by Next-Generation Sequencing

enthalten in: Frontiers in genetics | 2019

von About, F. | Bibert, S. | Jouanguy, E. | +51

4

Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients

enthalten in: American heart journal | 2018

von Cacoub, P. | Nahon, P. | Layese, R. | +83

5

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications

enthalten in: Gastroenterology | 2017

von Nahon, P. | Bourcier, V. | Layese, R. | +82

ErratumIn: Gastroenterology. 2021 Jul;161(1):377. - PMID 30817897

6

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications

enthalten in: Gastroenterology | 2017

von Nahon, P. | Bourcier, V. | Layese, R. | +46

7

Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort)

enthalten in: Gut | 2017

von Nahon, P. | Lescat, M. | Layese, R. | +40

8

Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort)

enthalten in: Gut | 2017

von Nahon, P. | Lescat, M. | Layese, R. | +62

9

Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir)

enthalten in: Hepatology (Baltimore, Md.) | 2016

von Ganne-Carrié, N. | Layese, R. | Bourcier, V. | +39

CommentIn: Hepatology. 2017 Mar;65(3):1074. - PMID 27680690

10

Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection : a phase 2, open-label, proof-of-concept study

enthalten in: The lancet. Gastroenterology & hepatology | 2016

von Lau, G. | Benhamou, Y. | Chen, G. | +22

CommentIn: Nat Rev Gastroenterol Hepatol. 2016 Oct;13(10 ):558. - PMID 27625193

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[22]